Related Experiment Video

Updated: Jul 18, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.3K

TREATMENT OPTIMIZATION IN MANAGEMENT OF COMBINED PATHOLOGY - ARTERIAL HYPERTENSION AND POST-COVID SYNDROME IN ELDERLY

Yurii M Kazakov1, Maksym M Potiazhenko1, Tetjana V Nastroga1

  • 1POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|August 25, 2023
PubMed

Insights

This study shows that adding L-arginine and mebicar to standard therapy effectively treats elderly patients with hypertension and post-COVID syndrome. This combination improves symptoms, lowers blood pressure, and enhances quality of life.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Geriatrics

Background:

  • Arterial hypertension (AH) and post-COVID syndrome are common comorbidities in elderly patients.
  • Effective management of this combined pathology is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the effectiveness of L-arginine and mebicar as adjunct therapies for elderly patients with AH and post-COVID syndrome.
  • To optimize treatment strategies within primary care settings.

Main Methods:

  • A study involving 50 elderly patients (average age 68.7 years) with AH and post-COVID syndrome.
  • Patients received basic antihypertensive therapy supplemented with statins, antiplatelet agents, L-arginine, and mebicar.

Main Results:

  • The combined therapy significantly reduced key clinical symptoms like headache and insomnia.
  • Significant improvements were observed in systolic blood pressure, anxiety levels, total cholesterol, and blood rheology.
  • Treatment accelerated symptom resolution compared to basic therapy alone.

Conclusions:

  • L-arginine and mebicar, as part of comprehensive treatment, optimize care for elderly patients with combined AH and post-COVID syndrome.
  • This therapeutic approach enhances patients' quality of life and shortens overall treatment duration.
Abstract

Keywords:
L-argininearterial hypertensionmebicarpost-COVID syndrome

More Related Videos

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

776
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

4.9K

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
14
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
11
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12